Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study

OBJECTIVE: Primary platinum-resistant epithelial ovarian cancer (EOC) is an area of unmet medical need. There is limited evidence from small studies that platinum-based combinations can overcome “resistance” in a proportion of patients. We investigated the efficacy and toxicity of platinum-based com...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayal, Karen, Gounaris, Ioannis, Basu, Bristi, Freeman, Sue, Moyle, Penny, Hosking, Karen, Iddawela, Mahesh, Jimenez-Linan, Mercedes, Abraham, Jean, Brenton, James, Hatcher, Helen, Earl, Helena, Parkinson, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Ovarian Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485738/
https://www.ncbi.nlm.nih.gov/pubmed/25962114
http://dx.doi.org/10.1097/IGC.0000000000000448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485738/
https://www.ncbi.nlm.nih.gov/pubmed/25962114
http://dx.doi.org/10.1097/IGC.0000000000000448

Ejemplares similares